T-bet knockout prevents Helicobacter felis-induced gastric cancer

C Stoicov, X Fan, JH Liu, G Bowen… - The Journal of …, 2009 - journals.aai.org
C Stoicov, X Fan, JH Liu, G Bowen, M Whary, E Kurt-Jones, JM Houghton
The Journal of Immunology, 2009journals.aai.org
Helicobacter infection is the primary risk factor for gastric cancer, with the cytokine
environment within the gastric mucosa the strongest predictor of disease risk. Elevated TNF-
α, IL-1β, and low IL-10 are associated with the highest risk. In this study, we used C57BL/6
mice to identify T-bet as a central regulator of the cytokine environment during Helicobacter
felis infection. We infected male and female C57BL/6 and C57BL/6-T-bet knockout (KO) liter
mates with H. felis and examined the bacterial colonization, immune response, and mucosal …
Abstract
Helicobacter infection is the primary risk factor for gastric cancer, with the cytokine environment within the gastric mucosa the strongest predictor of disease risk. Elevated TNF-α, IL-1β, and low IL-10 are associated with the highest risk. In this study, we used C57BL/6 mice to identify T-bet as a central regulator of the cytokine environment during Helicobacter felis infection. We infected male and female C57BL/6 and C57BL/6-T-bet knockout (KO) liter mates with H. felis and examined the bacterial colonization, immune response, and mucosal damage at varying time points. T-bet KO mice maintained infection for 15 mo at similar levels to wild-type mice. Infection and immune response did not differ between male and female mice. Despite sustained infection, T-bet KO mice respond with a blunted Th1 response associated with preservation of parietal and chief cells and protection from the development of gastric cancer. Unexpectedly, T-bet KO mice develop a gastric environment that would not be expected based on the phenotype of T-bet KO CD4 cells alone. T-bet KO mice respond to H. felis infection with a markedly blunted IL-1β and TNF-α and elevated IL-10 levels. Activity of this one master regulator modulates the expression of the key gastric mucosal cytokines associated with gastric cancer and may be a target for therapy to restore immune balance clinically in patients at risk for gastric cancer.
journals.aai.org